Scott C. Kachlany
Gründer bei Actinobac Biomed, Inc.
Aktive Positionen von Scott C. Kachlany
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Gründer | 17.07.2009 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 | - | |
| Direktor/Vorstandsmitglied | 01.01.2009 | - | |
| Corporate Officer/Principal | - | - | |
Leukovet
 Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Scott C. Kachlany
Ehemalige bekannte Positionen von Scott C. Kachlany
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | 01.01.2003 | - |
Ausbildung von Scott C. Kachlany
| Cornell University | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Health Technology |
- Börse
- Insiders
- Scott C. Kachlany
- Erfahrung